News and Events
Celebrating CCR Careers: Steven Z. Pavletic, M.D., Ph.D.
Steven Z. Pavletic, M.D., Ph.D., is a renowned expert in chronic graft-versus-host disease, a serious late complication that can happen after allogeneic bone marrow transplants. After serving at the NCI for over 20 years, he is now announcing his retirement.
Read More
A protein predicts poor breast cancer survival for women of African descent
CCR and Columbia University researchers have discovered that large amounts of the gp78 protein in breast cancer tumors predict worse outcomes for patients of African ancestry. Their findings provide some new understanding of a significant health disparity in breast cancer.
Read More
New way to classify meningioma brain tumors suggests potential treatments
Two studies have found a new way to classify meningioma, a type of tumor that forms in the outer covering of the brain. Kenneth Aldape, M.D., Chief and Senior Investigator of the Laboratory of Pathology, speaks about how the new grouping system may help predict whether a patient’s tumor will grow back after treatment and may reveal new treatment possibilities.
Read More
2022 Cancer Immunology and Immunotherapy Conference: Discovery to Mainstream Oncology
Registration and abstract submission is now open for the 2022 Cancer Immunology and Immunotherapy Conference: Discovery to Mainstream Oncology.
This two-day national conference provides a venue for scientists world-wide to exchange the latest information on the immunotherapy of cancer. We are looking forward to an exciting forum for discussion and debate on the current understanding of cancer and immunology and immunotherapy.
Sessions include:
- CAR T-Cell Based Immunotherapies
- Cell Therapy for Solid Epithelial Cancers
- Principles of Checkpoint Modulators
- Clinical Applications of Checkpoint Modulators
- Microbiome and Immunotherapy
- Factors Influencing the Success of Immunotherapy
- Innovative Approaches to Immunotherapy
Clinical trial researches immunotherapy for recurrent thymoma and thymic carcinoma
A clinical trial led by Arun Rajan, M.D., Senior Clinician in the Thoracic and GI Malignancies Branch, is researching treatments, including immunotherapy, for recurrent thymoma and thymic carcinoma.
Read More
Sung-Yun Pai selected for Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) Program
Sung-Yun Pai, M.D., Chief of the Immune Deficiency Cellular Therapy Program, was selected for the Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) Program for Women at Drexel University College of Medicine. The ELAM® program is dedicated to developing leadership and management skills in healthcare and is designed for senior-level women leaders interested in advancing hospitals and healthcare systems.
Read More
Celebrating Asian American, Native Hawaiian, and Pacific Islander Heritage Month: A Conversation with Lilian Yang, M.B.A.
Lilian Yang, M.B.A., is the Senior Branch Manager in the Neuro-Oncology Branch (NOB). She is originally from Hawaii and identifies as Chinese American. In this Asian American, Native Hawaiian, and Pacific Islander Heritage Month Q&A, she talks to us about the many places she has lived, some valuable business school advice, and the need for Asian representation in leadership roles.
Read More
Celebrating AANHPI Heritage Month: A Conversation with Suresh Ambudkar, Ph.D.
Suresh V. Ambudkar, Ph.D., is a Senior Investigator and the Deputy Chief of the Laboratory of Cell Biology. For this Asian American, Native Hawaiian, and Pacific Islander Heritage Month Q&A, he answers some questions about his academic, research and personal journey immigrating from India to the United States.
Read More
Clinical trial researching immunotherapy for B-cell lymphoma
A clinical trial led by Mark Roschewski, M.D., Senior Clinician in the Lymphoid Malignancies Branch, is researching immunotherapy for indolent B-cell lymphoma, a cancer of white blood cells that frequently relapses.
Read More
Machine learning reveals rules of T cell activation
CCR and McGill University scientists have used machine learning to build models that can predict T cell responses against tumors.
Read More
Clinical trial researches CAR T-cell therapy for hairy cell leukemia
Robert J. Kreitman, M.D., Senior Investigator in the Laboratory of Molecular Biology, is leading a study to see whether CAR T-cell therapy impacts patients with hairy cell leukemia.
Read More